Advocacy. Awareness. Access.

CalHEP News

BLOG POST: Pharmacists in California demonstrate that community pharmacies are viable locations for HCV screening & linkage to care

Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project Authors: Betty J.Dong, MariaLopez, Jennifer Cocohoba Objectives: To describe the first community pharmacy–based hepatitis C antibody (HCV-Ab) point-of-care (POC) screening program and its outcomes in California. Setting: Community pharmacy. Practice description: Community pharmacists perform HCV-Ab POC testing, counsel patients about HCV … Continue reading “BLOG POST: Pharmacists in California demonstrate that community pharmacies are viable locations for HCV screening & linkage to care”

Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project

Authors: Betty J.Dong, MariaLopez, Jennifer Cocohoba

Objectives: To describe the first community pharmacy–based hepatitis C antibody (HCV-Ab) point-of-care (POC) screening program and its outcomes in California.

Setting: Community pharmacy.

Practice description: Community pharmacists perform HCV-Ab POC testing, counsel patients about HCV transmission and prevention, and provide linkage to care.

Practice innovation: Pharmacists implement an HCV-Ab POC screening program in collaboration with the local public health department.

Evaluation: Descriptive data of the demographics of the persons receiving HCV-Ab POC screening and qualitative assessment of the attitudes and knowledge of the trained pharmacists involved in its implementation.

Results: During the 3-month pilot, 6 community pharmacists performed 83 HCV-Ab rapid POC tests with 1 positive result (1.2%). Risk factors for the positive result included injection drug use, crack cocaine or methamphetamine use, and being in the high-risk birth cohort. Although some expressed reservations, pharmacists attested to the feasibility of incorporating HCV screening into their routine pharmacy work. Two major barriers identified by pharmacists for implementing HCV screening included getting non-pharmacy customers into the pharmacy for testing and balancing the time required to review test results within the normal pharmacy workflow.

Conclusion: This pilot demonstrated that trained and motivated community pharmacists in partnership with the Department of Public Health could perform needed rapid HCV-Ab POC screening for potentially high-risk patients not currently in care. Community pharmacies are viable locations for screening and linkage to care owing to their easy access to knowledgeable pharmacists and accessible locations.

BLOG POST – June 7, 2017

Primary Care-Based HCV Treatment as Key to Access for Marginalized Populations:     A San Francisco Department of Public Health Case Study By Colleen Lynch, MD, Katie Burk, MPH, Kelly Eagen, MD, and Aaron Smith People who Inject Drugs (PWIDs) are highly impacted by the hepatitis C virus (HCV); estimates range from 50-90% HCV prevalence … Continue reading “BLOG POST – June 7, 2017”

Primary Care-Based HCV Treatment as Key to Access for Marginalized Populations:     A San Francisco Department of Public Health Case Study

By Colleen Lynch, MD, Katie Burk, MPH, Kelly Eagen, MD, and Aaron Smith

People who Inject Drugs (PWIDs) are highly impacted by the hepatitis C virus (HCV); estimates range from 50-90% HCV prevalence in this population. Recent broadening of Medi-Cal criteria for HCV treatment in California includes PWIDs as a priority population for HCV treatment. However, limited access to specialty care and treatment continues to be a significant barrier for many PWIDs and other vulnerable populations.

The San Francisco Health Network’s (SFHN) primary care clinics within the San Francisco Department of Public Health provide care to an urban, largely poor population with public or no insurance. It is estimated that there are at least 2,058 active patients in the SFHN (patients who have been seen at their primary care home in the past two years) who are chronically infected with HCV (estimated at 3.8% of the active, adult SFHN patient population).  Patients living with HCV are disproportionately African-American (n=819/40%), relative to 5-6% of African-Americans in San Francisco’s general population.

SFHN providers have significant expertise engaging PWIDs across the continuum of primary care, prevention, and drug treatment-related services. Having learned many important lessons about harm reduction and client-centered care during the worst years of the HIV crisis, SFHN supports broad syringe access and low-barrier access to methadone and buprenorphine through primary care and centralized methadone clinics. SFHN also employs skilled clinicians who work to retain PWIDs in primary care with impressive results.

With new curative treatments available for hepatitis C, San Francisco’s Health Department has made great strides to expand access to HCV prevention, testing, and treatment interventions. In early 2016, the California Department of Public Health (CDPH) awarded SFDPH a 3-year, $1.37 million award for community and clinic-based HCV testing, linkage, and treatment projects. The CDPH grant provides a nurse at Zuckerberg San Francisco General’s Opiate Treatment Outpatient Program (OTOP) to support an onsite HCV treatment project, a data analyst to track HCV metrics, and a capacity-building program for primary care-based HCV treatment.

The primary care initiative achieves dual goals of (1) expanding access to HCV treatment for patients in the SFHN network and (2) improving primary care physician (PCP) capacity to treat HCV.  The Health Department’s innovative model for expanding primary care-based HCV treatment includes HCV training for clinicians, the development of a primary care-driven web-based referral system (eReferral), and partnerships between the Health Department and community–based organizations.

Since the launch of the Hepatitis C Treatment Initiative on February 1 2016 through May 1 2016, approximately 227 SFHN clinical staff have participated in hour or multi-hour in-person trainings to learn how to treat hepatitis C within primary care. The eReferral, an electronic consultation service where primary care physicians can ask treatment questions (to whom) about individual patients through a secure messaging system, also launched on February 1 2016. A PCP and two clinical pharmacists experienced in Hepatitis C treatment staff the service. During this time period, 43 PCPs have utilized the HCV eReferral service for 123 patients, 50 of whom have started treatment. The majority of patients treated using eReferral consultation have co-occurring past or present substance use disorders, and approximately 34% of patients are African-American. Based on the current average treatment start rates of 25 patients per month, it is projected that approximately 300 patients will be treated in the SFHN Primary Care system in 2017, constituting 14.6% of the SFHN patient population living with HCV. The primary care-driven HCV treatment model is essential to making treatment accessible for PWIDs and other vulnerable populations.

Free Hep C Testing on May 19th in San Francisco

May 19, 2017 1:00pm-5:00 pm 2424 Mission St. (btw 20th & 21st St.), San Francisco, CA The San Francisco Hepatitis C Task Force is partnering with Mission Wellness Pharmacy to do outreach, education and free hepatitis C antibody testing on National Hepatitis Testing Day!

May 19, 2017
1:00pm-5:00 pm
2424 Mission St. (btw 20th & 21st St.), San Francisco, CA
The San Francisco Hepatitis C Task Force is partnering with Mission Wellness Pharmacy to do outreach, education and free hepatitis C antibody testing on National Hepatitis Testing Day!

Hepatitis C Testing Events in San Diego on National Hepatitis Testing Day

Family Health Centers of San Diego will be providing free hepatitis C testing at the following locations on Friday, May 19, 2017: Chula Vista Clinic (clinic also has hepatitis C providers) 9:00am-12:30pm 248 Landis Ave., Chula Vista, CA 91910   Pumpkin 12:00pm-4:00pm 4040 30th Street, San Diego, CA 92104   South Bay Adult Recovery Center … Continue reading “Hepatitis C Testing Events in San Diego on National Hepatitis Testing Day”

Family Health Centers of San Diego will be providing free hepatitis C testing at the following locations on Friday, May 19, 2017:

Chula Vista Clinic (clinic also has hepatitis C providers)

9:00am-12:30pm

248 Landis Ave., Chula Vista, CA 91910

 

Pumpkin

12:00pm-4:00pm

4040 30th Street, San Diego, CA 92104

 

South Bay Adult Recovery Center

11:00am-1:00pm

1180 Third Ave Suite 3, Chula Vista CA 91910

11am-1pm

 

CSEP (syringe exchange program)

9:30am-1:00pm

On 31st St. between University Avenue and North Park Way

May 19th Hepatitis Testing Day Event in Pasadena!

National Viral Hepatitis Testing Day Stakeholder Breakfast & Conference Friday, May 19, 2017 9:30am-noon Huntington Hospital, 100 W. California Blvd, Pasadena, CA 91105 Please RSVP by May 12 to kparada@apu.edu

National Viral Hepatitis Testing Day Stakeholder Breakfast & Conference

Friday, May 19, 2017

9:30am-noon

Huntington Hospital, 100 W. California Blvd, Pasadena, CA 91105

Please RSVP by May 12 to kparada@apu.edu

Lunch n’ Learn Events for Hepatitis Awareness Month

Our friends at Hepatitis Foundation International are hosting a series of online “lunch n’ learn” events for Hepatitis Awareness Month. The lunch n’ learn video series brings awareness about the viral hepatitis pandemic among “Hard to Treat, Hard to Reach” populations. For more information check out the Lunch n’ Learn Flyer.

Our friends at Hepatitis Foundation International are hosting a series of online “lunch n’ learn” events for Hepatitis Awareness Month.

The lunch n’ learn video series brings awareness about the viral hepatitis pandemic among “Hard to Treat, Hard to Reach” populations. For more information check out the Lunch n’ Learn Flyer.

Upcoming Events in Sacramento

On August 9, 2016, two important events will be held in Sacramento. 10:00am-12:00pm: Informational Hearing on Hepatitis B & C in California Chaired by Assembly Member Mike Gipson (D-Carson) State Capitol, Room 127 Agenda 12:30pm-4:30pm: CalHEP luncheon, awards ceremony & meeting Capitol Event Center, Executive Suites, 1020 11th Street RSVP for luncheon by August 4, … Continue reading “Upcoming Events in Sacramento”

On August 9, 2016, two important events will be held in Sacramento.

10:00am-12:00pm: Informational Hearing on Hepatitis B & C in California

Chaired by Assembly Member Mike Gipson (D-Carson)

State Capitol, Room 127

Agenda

12:30pm-4:30pm: CalHEP luncheon, awards ceremony & meeting

Capitol Event Center, Executive Suites, 1020 11th Street

RSVP for luncheon by August 4, 2016 by emailing ehuriaux@projectinform.org